Table: RaQualia Pharma -2023 group forecast
Dec 8 (Reuters) -
RaQualia Pharma Inc
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2023 Dec 31, 2023
LATEST PREVIOUS
FORECAST FORECAST
Sales 1.94 2.80
Operating loss 409 mln 260 mln
Recurring loss 340 mln 242 mln
Net loss 426 mln 183 mln
EPS loss 19.73 yen 8.74 yen
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T